J&J Medical Connect
INLEXZO™

(gemcitabine intravesical system)

This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

INLEXZO™ (gemcitabine intravesical system)

Patient Medical Information

What are the Ingredients in INLEXZO?

Last Updated: 09/10/2025

summary

  • The active ingredient in INLEXZO is gemcitabine hydrochloride.1 
  • The inactive ingredients for the gemcitabine component are polyethylene glycol 8000, povidone K30, and urea.1 
  • The inactive ingredients for osmotic components are FD&C Blue No.1, polyethylene oxide 600,000, and urea.1 

ADDITIONAL INFORMATION

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for INLEXZO.1

 

References

1 INLEXZO (gemcitabine intravesical system) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc; https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/INLEXZO-pi.pdf